Abstract:BACKGROUND:Hepatocellular carcinoma (HCC) ranked the second among the causes of cancer mortality in China since the 1990s. Up to now, medication still plays an important role in the treatment of HCC. The therapies based on the allicin as a potential chemopreventive analog although is in its infancy at the present time, may have a significant role in the future management of HCC. Diallyl trisulfide (DATS) is a natural compound derived from garlic. In this study, we investigated the inhibitory effects of hepatic targeted polybutylcyanoacrylate nanoparticles of diallyl trisulfide (DATS-PBCA-NP) on orthotopic transplanted HepG2 hepatocellular carcinoma in nude mice. METHODS:DATS-PBCA-NP were detected by transmission electron microscope (TEM) and high-performance liquid chromatography (HPLC). The orthotopic transplantation HCC models were established by implanting HCC HepG2 xenograft bits under the envelope of the mice liver. Successful models (n = 29) were divided into 4 groups: normal saline (NS), empty nanoparticles (EN), DATS and DATS-PBCA-NP were intravenously administered to the mice respectively for 2 weeks. In vivo antitumor efficacy was evaluated by the measurement of tumor volume. Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) assay and protein levels of apoptosis and cell proliferation proteins by immunoblotting in tumor tissues were performed to elucidate the possible mechanism. RESULTS:DATS-PBCA-NP possessed smooth and round appearance, dispersed well, and released in vitro in accord with double phase kinetics model. DATS-PBCA-NP changed the tissue/organ distribution of DATS in vivo. The successful rate of tumor implantation was 100%. Intravenous administration of DATS-PBCA-NP significantly retarded the growth of orthotopically transplanted hepatoma in BALB/c nude mice (compared with the other three groups, all P < 0.05) without causing weight loss (P > 0.05). TUNEL staining showed that the tumors from DATS-PBCA-NP treated mice exhibited a markedly higher apoptotic index compared with control tumors. Western blot analysis of tumor tissue revealed that the down-regulated expression of proliferation cell nuclear antigen (PCNA) and Bcl-2 proteins in DATS-PBCA-NP group, and there were no significant differences in the expression of Fas, FasL and Bax proteins among the four groups (P > 0.05). CONCLUSIONS:DATS-PBCA-NP has good prolonged release effect in vivo and hepatic-targeted activity, and significant anti-tumor effect on the orthotopic transplantation HCC model in mice in association with the suppression of proliferation and the induction of apoptosis of tumor cells. These advantages are probably due to their liver targeting characteristics and consequently bring a higher anti-tumor activity.

Liver Targeting and the Delayed Drug Release of the Nanoparticles of Adriamycin Polybutylcyanoacrylate in Mice

[Effect of Diameter of Adriamycin Polybutylcyanoacrylate Nanoparticles on Liver Targeting].

Body Distribution of Nanoparticle-Containing Adriamycin Injected into the Hepatic Artery of Hepatoma-Bearing Rats

Body Distribution of Nanoparticle Associated Adriamycin after Administration into the Hepatic Artery of Hepatoma Bearing Rats

Enhanced Antitumor Efficacy on Hepatoma-Bearing Rats with Adriamycin-Loaded Nanoparticles Administered into Hepatic Artery

Study on Targeting Distribution of Cisplatin Stealth Nanoparticles in Normal Mice

Polybutylcyanoacrylate Magnetic Nanoparticles As Carriers of Adriamycin.

Experimental study on the development and targeting effect of magnetic adriamycin nanoparticles

Study on Body Distribution and Hepatic Targeting Tendency of Galactosyl Adriamycin Bovine Serum Albumin Nanoparticles in Mice by Radioisotope Tracing

Study of the targetting distribution of epirubicin polybutylcyanoacrylate magnetic nanoparticles in rat hepatic

Preparation and Pharmacokinetics Study of Magnetic Doxorubicin Polybutylcyanoacrylate Nanoparticles

THE BIODISTRBUTION OF MAGNETICALBUMIN NANOPARTICLES CONTAINING ADRIAMYCIN

Study on Adverse Effects of Poly(N-isopropylacrylamide) Adriamycin Magnetic Nanoparticles Via Transarterial Embolization on Liver VX2 Tumor in Rabbits

Anti-tumor Effects of Polybutylcyanoacrylate Nanoparticles of Diallyl Trisulfide on Orthotopic Transplantation Tumor Model of Hepatocellular Carcinoma in BALB/c Nude Mice.

Study on the Liver Targeting of Oleanolic Acid Loaded Polybutylcyanoacrylate Nanocapsules in Mice

Research on targeting of O-Carboxymethylated Chitosan -PLA Adriamycin nanoparticles in rats

Preparation and properties of tumor-targeting lentinan-oleic acid polymer micelles based on folic acid for adriamycin delivery

Target Distribution of Magnetic Albumin Nanoparticles Containing Adriamycin in Model of Transplanted Liver Cancer in Rats

Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin

The Therapeutic Effects of Epirubicin Polybutyicyanoacrylate Nanoparticles Against Transplanted Liver Tumor

Study on the Anticarcinogenic Effect and Acute Toxicity of Liver-Targeting Mitoxantrone Nanoparticles